Barhemsys Injection, Solution
Product Images NDC 71390-125

5 FDA label images from Acacia Pharma Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Barhemsys (NDC 71390-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acacia Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Barhemsys 01)

Chemical Structure (Barhemsys 01)
Chemical structure diagram of the active ingredient Amisulpride, showing its molecular configuration with various functional groups.*
FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Principal Display Panel (2 mL Vial Carton)
Label for Barhemsys (amisulpride) injection, 5 mg in 2 mL solution (2.5 mg/mL) for intravenous infusion. The label indicates it is a single-dose sterile vial, with storage instructions to protect from light and store at 20°C to 25°C. Manufactured for Acacia Pharma Ltd, Indianapolis, IN.*
FDA Label Image

Barhemsys 03

Barhemsys 03
Packaging label for Barhemsys (amisulpride) injection, 5 mg/2 mL (2.5 mg/mL) single-dose sterile vial. The label indicates intravenous infusion use only and includes storage instructions. Manufactured by Acacia Pharma Ltd, with NDC 71390-125-21. The label also contains prescribing information references and dosage details.*
FDA Label Image

Barhemsys 04

Barhemsys 04
Barhemsys (amisulpride) injection, 10 mg in 4 mL (2.5 mg/mL) in a single-dose sterile vial. Label shows it is for intravenous infusion only, manufactured by Acacia Pharma Ltd, with handling instructions to store at 20°C to 25°C and use within 12 hours after removal from carton.*
FDA Label Image

Barhemsys 05

Barhemsys 05
Barhemsys (amisulpride) injection 10 mg/4 mL (2.5 mg/mL) intravenous solution in a single-dose sterile vial. The label includes dosage information, storage instructions at 20°C to 25°C, and a warning to protect from light. Manufactured by Acacia Pharma Ltd, the carton is designed for one 4 mL vial with patient information and barcodes visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.